Israeli-made dietary supplement fights off viruses in lab tests, scientists say

Israeli scientists say a special food supplement containing zinc, copper and chemicals that are found in fruit may help fight viruses, after they managed to inhibit virus replication in lab tests.

“We have a mixture of ingredients, each of which is already approved by the FDA as a food supplement, and together appear very capable of inhibiting replication of RNA viruses in a remarkable way,” Prof. Daniel Segal, from Tel Aviv University’s biomedicine school, told The Times of Israel.

However, he acknowledged that the peer-reviewed research took place in-vitro and gave no firm indication so far of what impact on humans the supplements may have.

Segal said that the mixture was tested in the lab on cells from human lungs and elsewhere, along with RNA viruses including those that cause flu and the common cold. Scientists found that virus replication was decreased by at least 50 percent compared to normal circumstances.

Beyond the zinc and copper, the compounds in the supplement are flavonoids, which are found in certain fruits and vegetables and are considered safe as a supplement.

Zinc is known to have anti-viral qualities, but also to struggle to enter cells. The other ingredients in the new supplement appear to bolster its ability to do so, Segal said.

An illustration of the virus cells (iStock via Getty Images)

SARS-CoV-2, the RNA virus that causes COVID-19, hasn’t yet been tested, but Segal said he is optimistic its replication may also be slowed given results on other viruses from the coronavirus family.

Prof. Daniel Segal, from Tel Aviv University’s biomedicine school (courtesy of Tel Aviv University)

Segal and his colleagues wrote in their study, which was published in the journal Pharmaceuticals: “Such an inexpensive combination of dietary supplements would be highly advantageous to have, alongside vaccines, as a safe prevention method affecting various RNA respiratory viruses.”

Prof. Ehud Gazit, head of Tel Aviv University’s Blavatnik Center for Drug Discovery and part of the study, commented: “These results are very promising, possibly enabling the development of an orally administered treatment.”

He said that such a product would reflect an “important step forward,” as it would be safe, natural, and potentially effective against a range of viruses and variants.

We’re telling a critical story

Israel is now a far more prominent player on the world stage than its size suggests. As The Times of Israel’s Diplomatic Correspondent, I’m well aware that Israel’s security, strategy and national interests are always scrutinized and have serious implications.

It takes balance, determination, and knowledge to accurately convey Israel’s story, and I come to work every day aiming to do so fully. 

Financial support from readers like you allows me to travel to witness both war (I just returned from reporting in Ukraine) and the signing of historic agreements. And it enables The Times of Israel to remain the place readers across the globe turn to for accurate news about Israel’s relationship with the world.

If it’s important to you that independent, fact-based coverage of Israel’s role in the world exists and thrives, I urge you to support our work. Will you join The Times of Israel Community today?

Thank you,

Lazar Berman, Diplomatic Correspondent

Yes, I’ll give

Yes, I’ll give

Already a member? Sign in to stop seeing this

You’re a dedicated reader

That’s why we started the Times of Israel ten years ago – to provide discerning readers like you with must-read coverage of Israel and the Jewish world.

So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.

For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.

Thank you,
David Horovitz, Founding Editor of The Times of Israel

Join Our Community

Join Our Community

Already a member? Sign in to stop seeing this

By Percy